Bioheart to Present At the Cell & Gene Therapy Forum in Washington, D.C.
January 22, 2009 08:00 ET
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 22, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure...
Bioheart, Inc. Elects Dr. Karl Groth to Its Board of Directors and Appoints Peggy Farley to Chairman of the Audit Committee
January 20, 2009 21:32 ET
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 20, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced that it has elected Dr. Karl Groth, a co-founder of the Ascent Medical Technology Fund, to its Board of...
Bioheart, Inc. Reports Receipt of Notification From NASDAQ Regarding Non-Compliance With Continued Listing Requirements
January 20, 2009 16:35 ET
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 20, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) today announced that it received a letter from the Nasdaq Stock Market on January 14, 2009 advising that, the Company does...
Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients
January 14, 2009 10:54 ET
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT)
announced today it has received a purchase order for a TGI 1200 System from
Philadelphia BioMed Product Development...
Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients
January 14, 2009 10:35 ET
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 14, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has received a purchase order for a TGI 1200 System from Philadelphia BioMed Product Development...
Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
January 13, 2009 10:52 ET
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT)
announced today it has filed with appropriate agencies in Switzerland for
reimbursement approval for its MyoCell(r)...
Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
January 13, 2009 10:42 ET
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 13, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has filed with appropriate agencies in Switzerland for reimbursement approval for its MyoCell(r)...
Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure
January 12, 2009 23:52 ET
|
Bioheart, Inc.
Four Years of Sponsored Animal Studies At Cleveland Clinic and the University
of Florida Have Demonstrated That Second-generation Cell Therapy, MyoCell(r)
SDF-1, Provides Double the Level of...
Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure
January 12, 2009 10:07 ET
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 12, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today that it plans to conduct clinical trials for its second-generation MyoCell SDF-1 myogenic cell composition...
Bioheart Collaborating Researchers to Present At the Fifth International Conference on Cell Therapy for Cardiovascular Disease in New York, January 14-16, 2009
January 09, 2009 13:56 ET
|
Bioheart, Inc.
SUNRISE, Fla., Jan. 9, 2009 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT), a company developing core technologies aimed at serving the heart failure patient population, announced today that eight...